Delcath Systems, Inc. Earnings Conference Call (Q4 2012)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Mar 13 Calls Today's Calls

Call Details Delcath Systems, Inc. Earnings Conference Call (Q4 2012) Scheduled to start Wed, Mar 13, 2013, 4:30 pm Eastern This event is scheduled to be ongoing now. However, we don't yet have information on the audio stream. About Delcath Systems Inc (NasdaqCM:DCTH) Other Calls  Delcath Systems, Inc., a development stage company, develops and manufactures devices to administer high dose chemotherapy and other therapeutic agents directly to diseased organs or regions of the body. It focuses on the development of the Delcath PHP System, a Phase III clinical trial product, which isolates the liver from the patient’s general circulatory system and delivers high dose of melphalan hydrochloride or other therapeutic agents directly to the liver. The Delcath PHP System kit includes an arterial infusion catheter, a multi-passageway/double balloon catheter, a blood tubing filtration circuit, two hemoperfusion filters, a return catheter/a thin-walled blood sheath, and a series of introducers and related accessories to properly place the catheters. The company also conducts Phase II clinical trials to test the Delcath PHP System with melphalan against liver cancer, neuroendocrine tumors, hepatocellular carcinoma, ocular or cutaneous melanoma, and metastatic adenocarcinoma that have spread to the liver, and melanomas metastatic to the liver that have received prior regional treatment. It has a cooperative research and development agreement with the National Cancer Institute to develop and evaluate the Delcath PHP System device. Delcath Systems, Inc. was founded in 1988 and is based in New York, New York. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings